Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
Clinical trial NCT03829462 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03829462
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2024-09-04
- Enrollment
- 377
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.